Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Roivant Sciences Ltd.ROIV · Entity 3185 | CFO | September 20, 2026 | September 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Roivant Sciences Ltd.
Report date September 20, 2026 · Filed September 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 269,681 |
Reported balance
After 2026-09-20 transaction · row 1
1 source rowRow 1 · 2026-09-20 · Tax withholding · Disposed 2,129 · Balance 269,681 F1: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 20, 2026 Filed Sep 22, 2026 22:26 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,129 | $39.77 | $84,670.33 |
DisclosureSEC source: 0001635088-26-000104 · wk-form4_1790116002.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,681 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| August 20, 2026 Filed Aug 25, 2026 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 5,749 | $36.84 | $211,793.16 |
DisclosureSEC source: 0001140361-26-034239 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,810 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. F2 · balance_after: Includes Common Shares purchased under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 20, 2026 Filed Jun 24, 2026 01:17 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,129 | $31.43 | $66,914.47 |
DisclosureSEC source: 0001635088-26-000069 · wk-form4_1782263852.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,420 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| May 20, 2026 Filed May 22, 2026 22:22 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 18,962 | $32.41 | $614,558.42 |
DisclosureSEC source: 0001635088-26-000064 · wk-form4_1779488534.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,549 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 22:26 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | GrantStock Option (Right to Buy) · Derivative | 84,026 | $0.00 Strike: $29.08 | $0.00 |
DisclosureSEC source: 0001635088-26-000043 · wk-form4_1776896805.xml · derivative · entry 2 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,026 Underlying: Common Shares · 84,026 shares Expires 2036-04-19 F2 · derivative.exercise_date: Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2026. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in thirty-six (36) successive equal monthly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 22:26 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | GrantCommon Shares | 60,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001635088-26-000043 · wk-form4_1776896805.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 297,511 F1 · shares: Reflects an award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2026. These RSUs vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in twelve (12) successive equal quarterly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 23:08 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,546 | $27.70 | $42,824.20 |
DisclosureSEC source: 0001635088-26-000030 · wk-form4_1774393730.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,867 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:43 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,000 | $27.15 | $27,150.00 |
DisclosureSEC source: 0001635088-26-000023 · wk-form4_1771976631.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,413 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Exercise / conversionStock Option (Right to Buy) · Derivative | 260,000 | $0.00 Strike: $3.85 | $0.00 |
DisclosureSEC source: 0001140361-25-046787 · form4.xml · derivative · entry 4 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 740,000 Underlying: Common Stock · 260,000 shares Expires 2032-04-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation). Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 146,731 | $22.39 | $3,285,307.09 |
DisclosureSEC source: 0001140361-25-046787 · form4.xml · nonDerivative · entry 3 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,413 F1 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. F3 · price: These Common Shares were sold in multiple transactions at prices ranging from $22.28 to $22.54, inclusive. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 260,000 | $22.45 | $5,837,000.00 |
DisclosureSEC source: 0001140361-25-046787 · form4.xml · nonDerivative · entry 2 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,144 F1 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. F2 · price: These Common Shares were sold in multiple transactions at prices ranging from $22.37 to $22.51, inclusive. Read SEC document |
| December 23, 2025 Filed Dec 30, 2025 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Exercise / conversionCommon Shares | 260,000 | $3.85 | $1,001,000.00 |
DisclosureSEC source: 0001140361-25-046787 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 646,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2025 Filed Dec 24, 2025 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,129 | $22.41 | $47,710.89 |
DisclosureSEC source: 0001140361-25-046601 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,144 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| November 20, 2025 Filed Nov 25, 2025 02:02 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,235 | $20.27 | $25,033.45 |
DisclosureSEC source: 0001140361-25-043203 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 388,273 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| September 28, 2025 Filed Oct 1, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,341 | $15.17 | $35,512.97 |
DisclosureSEC source: 0001140361-25-036831 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 389,508 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| September 20, 2025 Filed Sep 24, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,129 | $15.04 | $32,020.16 |
DisclosureSEC source: 0001140361-25-035891 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,849 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| August 28, 2025 Filed Sep 3, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,340 | $11.94 | $27,939.60 |
DisclosureSEC source: 0001140361-25-033687 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 393,978 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| August 20, 2025 Filed Aug 23, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,235 | $11.72 | $14,474.20 |
DisclosureSEC source: 0001140361-25-032405 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 396,318 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| July 28, 2025 Filed Jul 31, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,919 | $11.35 | $21,780.65 |
DisclosureSEC source: 0001140361-25-028078 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 397,553 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| June 28, 2025 Filed Jul 2, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,653 | $11.39 | $18,827.67 |
DisclosureSEC source: 0001140361-25-024434 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,472 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. F2 · balance_after: Includes Common Shares purchased under the Company's Employee Stock Purchase Plan. Read SEC document |
| June 20, 2025 Filed Jun 25, 2025 01:01 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,503 | $11.45 | $17,209.35 |
DisclosureSEC source: 0001140361-25-023522 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,056 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| May 28, 2025 Filed May 31, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,653 | $10.62 | $17,554.86 |
DisclosureSEC source: 0001140361-25-020985 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,559 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| May 20, 2025 Filed May 23, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 3,487 | $11.04 | $38,496.48 |
DisclosureSEC source: 0001140361-25-020242 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,212 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| April 28, 2025 Filed May 1, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,653 | $11.19 | $18,497.07 |
DisclosureSEC source: 0001140361-25-016748 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,699 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| April 21, 2025 Filed Apr 24, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | GrantStock Option (Right to Buy) · Derivative | 180,413 | $0.00 Strike: $10.04 | $0.00 |
DisclosureSEC source: 0001140361-25-015254 · form4.xml · derivative · entry 2 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,413 Underlying: Common Shares · 180,413 shares Expires 2035-04-20 F2 · derivative.exercise_date: Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2025. These options vest and become exercisable as follows: (i) 25% on the first anniversary of the vesting commencement date; and (ii) in thirty-six (36) successive equal monthly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| April 21, 2025 Filed Apr 24, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | GrantCommon Shares | 141,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-015254 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 407,352 F1 · shares: Reflects an award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2025. These RSUs service-vest as follows: (i) 25% on the date thirteen (13) months from the vesting commencement date; and (ii) in twelve (12) successive equal quarterly installments thereafter, measured from the date thirteen (13) months from the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| March 28, 2025 Filed Apr 2, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,653 | $10.38 | $17,158.14 |
DisclosureSEC source: 0001140361-25-011688 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,888 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| March 20, 2025 Filed Mar 25, 2025 01:01 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,504 | $10.97 | $16,498.88 |
DisclosureSEC source: 0001140361-25-010118 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,541 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 02:11 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,635 | $10.74 | $17,559.90 |
DisclosureSEC source: 0001140361-25-007010 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,045 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| January 28, 2025 Filed Jan 31, 2025 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,896 | $11.15 | $21,140.40 |
DisclosureSEC source: 0001140361-25-002490 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,680 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| December 28, 2024 Filed Jan 1, 2025 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,896 | $11.80 | $22,372.80 |
DisclosureSEC source: 0001140361-24-050724 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,576 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| December 20, 2024 Filed Dec 27, 2024 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,129 | $11.57 | $24,632.53 |
DisclosureSEC source: 0001140361-24-050460 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,472 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| November 28, 2024 Filed Dec 3, 2024 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,341 | $12.69 | $29,707.29 |
DisclosureSEC source: 0001140361-24-048223 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,601 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,341 | $11.84 | $27,717.44 |
DisclosureSEC source: 0001140361-24-044666 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,942 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| September 28, 2024 Filed Oct 2, 2024 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,340 | $11.48 | $26,863.20 |
DisclosureSEC source: 0001140361-24-042520 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,283 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| September 20, 2024 Filed Sep 25, 2024 01:01 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,129 | $11.97 | $25,484.13 |
DisclosureSEC source: 0001140361-24-041787 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,623 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| August 28, 2024 Filed Aug 31, 2024 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,341 | $12.00 | $28,092.00 |
DisclosureSEC source: 0001140361-24-039820 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 285,752 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| July 28, 2024 Filed Jul 31, 2024 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,341 | $10.80 | $25,282.80 |
DisclosureSEC source: 0001140361-24-034980 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 288,093 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 01:01 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,340 | $10.57 | $24,733.80 |
DisclosureSEC source: 0001140361-24-032045 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 290,434 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. F2 · balance_after: Includes Common Shares purchased under the Company's Employee Stoch Purchase Plan. Read SEC document |
| June 20, 2024 Filed Jun 25, 2024 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,129 | $10.80 | $22,993.20 |
DisclosureSEC source: 0001140361-24-031176 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 290,572 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| May 28, 2024 Filed May 31, 2024 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,341 | $10.83 | $25,353.03 |
DisclosureSEC source: 0001140361-24-028223 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 292,701 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| April 28, 2024 Filed May 1, 2024 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,340 | $11.03 | $25,810.20 |
DisclosureSEC source: 0001140361-24-023519 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 295,042 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| April 22, 2024 Filed Apr 25, 2024 01:12 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | GrantStock Option (Right to Buy) · Derivative | 302,594 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001140361-24-021817 · form4.xml · derivative · entry 2 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302,594 Underlying: Common Shares · 302,594 shares Expires 2034-04-21 F2 · derivative.exercise_date: Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2024. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date. Read SEC document |
| April 22, 2024 Filed Apr 25, 2024 01:12 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | GrantCommon Shares | 38,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-021817 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 297,382 F1 · shares: Reflects an award of 38,685 restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2024. 1/4 of the RSUs service-vest on the date thirteen (13) months from the vesting commencement date; and the balance of the RSUs service-vest in series of twelve (12) successive equal quarterly installments measured from the date thirteen (13) months from the vesting commencement date, subject to the reporting person's Continuous Service through the applicable vesting date. Read SEC document |
| April 20, 2024 Filed Apr 24, 2024 01:01 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 8,515 | $10.46 | $89,066.90 |
DisclosureSEC source: 0001140361-24-021494 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 258,697 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs Read SEC document |
| March 28, 2024 Filed Apr 3, 2024 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 2,341 | $10.54 | $24,674.14 |
DisclosureSEC source: 0001140361-24-017375 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 267,212 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,630 | $11.71 | $19,087.30 |
DisclosureSEC source: 0001140361-24-010864 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,553 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| January 28, 2024 Filed Jan 31, 2024 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,896 | $10.37 | $19,661.52 |
DisclosureSEC source: 0001140361-24-004651 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 271,183 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| December 28, 2023 Filed Dec 30, 2023 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 1,913 | $11.37 | $21,750.81 |
DisclosureSEC source: 0001140361-23-060294 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 273,079 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| November 29, 2023 Filed Dec 2, 2023 02:31 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 2,360 | $9.13 | $21,546.80 |
DisclosureSEC source: 0001140361-23-055910 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 274,922 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.